Mert Erkan

The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.

Helmut Friess, H. Friess, J. Kleeff, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The role of hypoxia in pancreatic cancer: a potential therapeutic target?

J. Kleeff, M. Kurtoğlu, M. Erkan, 2016, Expert review of gastroenterology & hepatology.

βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer

David Goldstein, Maria Kavallaris, Andrew V. Biankin, 2014, Oncotarget.

Northern blot analysis for detection and quantification of RNA in pancreatic cancer cells and tissues

Helmut Friess, H. Friess, J. Kleeff, 2008, Nature Protocols.

Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.

Tomas Mitkus, Helmut Friess, H. Friess, 2007, Gastroenterology.

The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

Alexander A. Fingerle, Martin Dobritz, Helmut Friess, 2012, Nature Reviews Gastroenterology &Hepatology.

Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

Ernst J Rummeny, Jens T Siveke, Marcus Settles, 2016, Clinical Cancer Research.

Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.

Helmut Friess, H. Friess, J. Kleeff, 2009, Neoplasia.

A common genetic variation of melanoma inhibitory activity-2 labels a subtype of pancreatic adenocarcinoma with high endoplasmic reticulum stress levels

Bo Kong, Helmut Friess, H. Friess, 2015, Scientific Reports.

Intracellular autofluorescence: a biomarker for epithelial cancer stem cells

Manuel Hidalgo, Diego Megias, Aldo Scarpa, 2014, Nature Methods.